2 papers
stat.ME2020
Statistical design considerations for trials that study multiple indications
Alexander M. Kaizer, Joseph S. Koopmeiners, Nan Chen +1
Breakthroughs in cancer biology have defined new research programs emphasizing the development of therapies that target specific pathways in tumor cells. Innovations in clinical tr…
stat.ME2020
Borrowing from Supplemental Sources to Estimate Causal Effects from a Primary Data Source
Jeffrey A. Boatman, David M. Vock, Joseph S. Koopmeiners
The increasing multiplicity of data sources offers exciting possibilities in estimating the effects of a treatment, intervention, or exposure, particularly if observational and exp…